N,N-Diethyl-(2-(4-(2-(18F)Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo(1,5-A)Pyrimidine-3-Yl)Acetamide

3 trials 1 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

1 Countries

Phase II

Phase IV

Phase II: 2 Phase IV: 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 3

All trials

3 total

Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. Pending

2025-521923-58-00 Phase II 1 country Centre Hospitalier Universitaire De Toulouse
Is [18F]-DPA-714 PET a good marker of neuroinflammation in autoimmune encephalitis? (EAI-714) Recruiting

2025-522768-33-00 Phase II 1 country Centre Hospitalier Universitaire De Toulouse
Cerebral neuroinflammation during major depressive episode: multicentric comparative study (InflaDep) Ended

2024-518405-18-00 Phase IV 1 country Centre Hospitalier Universitaire De Toulouse

Showing 1–3 of 3 trials

← All drugs A–Z